CONSTANT LEVERAGE LONG - PFIZER INC | Market Closed - Euronext Paris 12:30:01 2024-06-25 EDT | ||
| 0.224 EUR | +0.90% |
|
| Current month | -8.57% | ||
| 1 month | -10.76% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
PFIZER, INC.
Latest news about PFIZER, INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-25 | 0.224 | +0.90% |
| 24-06-24 | 0.222 | +5.21% |
| 24-06-21 | 0.211 | -4.09% |
| 24-06-20 | 0.22 | +7.32% |
| 24-06-19 | 0.205 | +3.02% |
Real-time Euronext Paris
Last update June 25, 2024 at 12:30 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | PFIZER, INC. |
| Issuer | 
BNP Paribas
|
| 4ZLEB | |
| ISIN | NLBNPNL1M1U0 |
| Date issued | 2022-01-21 |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.315 € |
|---|---|
| Lowest since issue | 0.159 € |
| Spread | 0.002 € |
| Spread % | 0.89% |
Company Profile
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:
- primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;
- specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;
- oncology products (12.1%);
- other (1.3%).
At the end of 2022, the group had more than 35 manufacturing sites worldwide.
Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
Consensus: Pfizer, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.99
USD
Average target price
31.92
USD
Spread / Average Target
+14.02%
- Stock Market
- Certificates
- 4ZLEB Certificat
